AD9-29020-60713
3 vaccinations
2 coded responses
13 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 981 / WA
- Registered
- 2022-10-26
- Relationship
- Child or adolescent in my care
- Guardian
- SYB-45488-76469
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-10
Dose 1 — Pfizer-BioNTech
-
2021-12-02
Dose 2 — Pfizer-BioNTech
-
2022-10-25
Dose 3 — Pfizer-BioNTech
-
2022-10-26
Registered in v-safe
-
2022-10-26
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · NauseaAdult check-in
-
2022-10-28
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-10-29
- 2022-10-30
- 2022-10-31
-
2022-11-02
Survey response — day 7, dose 3, dependentMedDRA: SARS-CoV-2 test negative, Viral infection — Feeling: Fair · Fatigue or tiredness, NauseaFree text: Likely a secondary viral illness from school, COVID negativeMedDRA releases: 2024-11 · check-in free text available
-
2022-11-09
Survey response — day 14, dose 3, dependentMedDRA: Vision blurred — Feeling: GoodFree text: Intermittent transient blurry visionMedDRA releases: 2024-11 · check-in free text available
- 2022-11-15
- 2022-11-22
- 2022-11-29
- 2022-12-06
- 2023-01-26
- 2023-04-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-10 | Pfizer-BioNTech | No |
| 2 | 2021-12-02 | Pfizer-BioNTech | No |
| 3 | 2022-10-25 | Pfizer-BioNTech | No |
Free text
Release 12 — day 7, dose 3, dependent
Systemic reaction (other): Likely a secondary viral illness from school, COVID negative
Release 12 — day 14, dose 3, dependent
Symptoms: Intermittent transient blurry vision
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Vision blurred | · | · | ✓ |
| SRO | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release